Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well ToleratedRamzi Abboud, Rizwan Romee, Camille N. Abboud et al.|Biology of Blood and Marrow Transplantation|2016Cited by 164
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J. Duncavage, Matthew J. Walter, Meagan A. Jacoby et al.|New England Journal of Medicine|2018Cited by 121
Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell TransplantationKendall C. Shultes, Sean DeFrates, Christopher J. Arp et al.|Biology of Blood and Marrow Transplantation|2017Cited by 6
Influence of Body Weight on Melphalan Dosing in Autologous Stem Cell TransplantationKendall C. Shultes, Sean DeFrates, Christopher J. Arp et al.|Biology of Blood and Marrow Transplantation|2017Cited by 1